Author(s):
Hanna I. Severina, Svitlana M. Gubar, Ivan V. Bezruk, Anna S. Materiienko, Liudas Ivanauskas, Vera A. Bunyatyan, Sergiy M. Kovalenko, Olha O. Scupa, Victoriya A. Georgiyants
Email(s):
severina.ai@ukr.net
DOI:
10.52711/0974-360X.2021.00561
Address:
Hanna I. Severina1*, Svitlana M. Gubar1, Ivan V. Bezruk1, Anna S. Materiienko1, Liudas Ivanauskas2, Vera A. Bunyatyan3, Sergiy M. Kovalenko4, Olha O. Scupa5, Victoriya A. Georgiyants1
1National University of Pharmacy, 53 Pushkinska Str., 61002, Kharkiv, Ukraine.
2Lithuanian University of Health Sciences, Sukileliu Av. 13, Kaunas, LT-50162, Lithuania.
3 Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University). 8 Trubeckaya St., Moscow 119991, Russia.
4V.N. Karazin Kharkiv National University, 4 Svobody Sq., Kharkiv, 61077, Ukraine.
5National Pirogov Memorial Medical University, 56 Pirogova St., Vinnytsya 21018, Ukraine.
*Corresponding Author
Published In:
Volume - 14,
Issue - 6,
Year - 2021
Cite this article:
Hanna I. Severina, Svitlana M. Gubar, Ivan V. Bezruk, Anna S. Materiienko, Liudas Ivanauskas, Vera A. Bunyatyan, Sergiy M. Kovalenko, Olha O. Scupa, Victoriya A. Georgiyants. Development and Validation of HPLC Determination of related Substances in A Novel Anticonvulsant agent Epimidin. Research Journal of Pharmacy and Technology. 2021; 14(6):3223-1. doi: 10.52711/0974-360X.2021.00561